Supplement Research and Development, LLC acquires intellectual property of AmeriSciences®
Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact email@example.com.
Supplement Research and Development, LLC d/b/a AmeriSciences® has acquired the intellectual property, assets and formulations of AmeriSciences, LP, a former supplier of scientifically-based, nutritional supplements for general health, eye health, weight management, and joint mobility.
FORT MYERS, Fla., Dec. 23, 2013 /PRNewswire/ -- Supplement Research and Development, LLC d/b/a AmeriSciences® has acquired the intellectual property, assets and formulations of AmeriSciences, LP, a former supplier of scientifically-based, nutritional supplements for general health, eye health, weight management, and joint mobility. Supplement Research and Development is an intellectual property, research and development, distribution, and licensing company operating in Florida and Texas, with corporate office at 12381 S. Cleveland Avenue, Suite 205 in Fort Myers, FL 33919.
AmeriSciences LP was first incorporated in 1999. In 2004, it entered into a Space Act Agreement with the National Aeronautics and Space Administration (NASA) at the Johnson Space Center in Houston, TX. The collaboration resulted in developing revolutionary multivitamin, antioxidant, and performance supplements to counter radiation damage and other environmental stress factors commonly found in air and space travel, scuba diving, radiology diagnostics and procedures, nuclear power plants, mines, refineries, and elsewhere.
Carlos Montesinos, former Director of Product Development of AmeriSciences, LP has been named President and CEO of Supplement Research and Development. Montesinos led scientific product development of AmeriSciences® brand products from 2000 until it ceased operations in May 2012. Montesinos plans to expand product development internationally through research and development partnerships with leading scientists and public and private institutions.
When asked about the company's future, Montesinos said, "A key AmeriSciences® product advantage has always been the superior bioavailability of our tablets that dissolve at the rate of 95%--which is unparalleled in the nutrition and pharmaceutical industries. We will continue to build on that pedigree and focus on adding value to medical practices seeking effective wellness solutions for their patients."
After AmeriSciences, LP ceased operations in 2012, product distributor Tammy Provence, founder and owner of HealthCheckMD in Fort Myers, FL secured an intellectual property license to continue product manufacturing and distribution. She also realigned the sales model from direct sales to e-commerce and expanded wholesale distribution.
AmeriSciences® nutritional supplements are again readily available for purchase through physicians' offices, specialty health and wellness retailers, and online. For more information, visit www.AmeriSciences.com or call 239-931-1710.
Two lots of Pfizer's antidepressant drug Effexor XR (venlafaxine HCl) are being recalled because they may contain capsules of another drug called Tikosyn (dofetilide).More >>
Two lots of Pfizer's antidepressant drug Effexor XR (venlafaxine HCl) are being recalled because they may contain capsules of another drug called Tikosyn (dofetilide), which is used to treat heart rhythm disorders.More >>